Doxorubicin Induced Cardiomyopathy
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00380 | Dexrazoxane | A cytoprotective drug used to prevent and improve cardiomyopathy associated with doxorubicin treatment for metastatic breast cancer. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00380 | Dexrazoxane | DNA topoisomerase 2-alpha | target |
| DB00380 | Dexrazoxane | DNA topoisomerase 2-beta | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01076 | Atorvastatin | 2 / 3 | Recruiting | 1 |
| DB00997 | Doxorubicin | Not Available | Completed | 1 |
| DB09132 | Gadoteric acid | Not Available | Completed | 1 |